Micro Developing Active

LLY GLP-1 프랜차이즈 성장

점수
0.5
모멘텀
▲ 0.0
기사
13
출처
4

요약

이 기사는 Eli Lilly의 GLP-1 프랜차이즈 의약품 성장 관련 내용을 보고하는 경우 해당 내러티브에 속합니다.

관련 기사

US approves new oral weight-loss pill developed by Eli Lilly

The Guardian · 4월 02, 2026
Mixed

Why Eli Lilly Stock Trounced the Market Today

Nasdaq · 4월 01, 2026
Mixed

Eli Lilly vs Novo Nordisk: Which Obesity Drug Stock Is the Better Buy?

Nasdaq · 3월 27, 2026
Mixed

출처

US approves new oral weight-loss pill developed by Eli Lilly The Guardian
Eli Lilly Is Bringing AI-Developed Drugs to Market. Should You … Yahoo Finance
Why Eli Lilly Stock Trounced the Market Today Nasdaq
FDA approves Eli Lilly's GLP-1 pill, opening the next phase … CNBC
Eli Lilly and Company (LLY) Continued to Gain from Its … Yahoo Finance
Eli Lilly’s (LLY) Shares Up Since Jim Cramer Said He … Yahoo Finance
GSK (GSK) Shares Up Significantly Since Jim Cramer Said to … Yahoo Finance
Mounjaro maker wants NHS drug price rises in return for … The Guardian
Jefferies Remains a Buy on Eli Lilly and Company (LLY) Yahoo Finance
Eli Lilly vs Novo Nordisk: Which Obesity Drug Stock Is … Nasdaq
Hims & Hers Expands Access To Novo Nordisk's FDA-Approved GLP-1 … Nasdaq
Eli Lilly (LLY) Gained From Growth in its GLP-1 Franchises … Yahoo Finance

타임라인

최종 업데이트 3월 27, 2026